Gossamer Bio, Inc. (GOSS)

NASDAQ: GOSS · USD

$10.8

+1.03 (+10.5%)· Recorded snapshot

Market cap	66.1M
Revenue (ttm)	53.3M
Net income (ttm)	-125.2M
EPS (ttm)	-$52.0
Shares out	6.1M
Volume	173,586
Beta	2.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.3M
Net income (ttm): -125.2M
EPS (ttm): -$52.0
Market cap: 66.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-192.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GOSS indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001728117
Company name	Gossamer Bio, Inc.
Country	United States
Country code	US
CUSIP number	38341P201
Earnings date	2026-11-09
Earnings time	amc
Employees	162
Employees change	17
Employees growth	11.72%
Enterprise value	$49.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2019-02-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US38341P2011
Last 10-K release date	2026-03-17
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-09-11
Last stock split type	Reverse
Market cap	$66.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$10.80
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GOSS
U.S. state	California
Website	https://www.gossamerbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-481.2%
EV/Sales	0.85x
FCF / EV yield	-357.98%
FCF yield	-260.67%
Forward EV/Sales	2.7x
Forward P/S	3.7x
P/S ratio	1.17x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-297.67%
EBITDA margin	-297.63%
Gross margin	100%
Operating margin	-297.67%
Pretax margin	-235.17%
Profit margin	-235%
Profit per employee	$-772,981
Profitable quarters	1
Revenue per employee	$328,926
ROA	-62.39%
ROA (5Y)	-33.18%
ROCE	260.39%
ROIC	-192.94%
SBC / revenue	26.89%
Tax / revenue	-0.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	32.43%
Gross profit growth (Q)	-19.59%
Net income growth quarters	1
Net income growth years	0
Revenue growth	32.43%
Revenue growth (Q)	-19.59%
Revenue growth (QoQ)	-45.51%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$21,000
EBIT	$-158.6M
EBITDA	$-158.6M
EPS	$-51.97
FCF per share	$-26.59
Financing cash flow	$3.2M
Free cash flow	$-162.6M
Free cash flow minus SBC	$-177M
Gross profit	$53.3M
Income taxes	$-88,000
Investing cash flow	$174.5M
Net cash flow	$14.8M
Net income	$-125.2M
Operating cash flow minus SBC	$-177M
Operating income	$-158.6M
Revenue	$53.3M
Stock-based compensation	$14.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-32.47
Book value per share	$-15.39
Interest coverage	-14.47
Long-term assets	$4.1M
Long-term liabilities	$33.1M
Net cash (debt)	$17M
Net cash / market cap	27.18%
Net cash growth	68.15%
Piotroski F-Score	1
Property, plant and equipment	$3.7M
Shareholders' equity	$-94M
Tangible book value	$-94M
Tangible book value per share	$-15.39
Total assets	$76.9M
Total cash	$57M
Total debt	$40.1M
Total liabilities	$170.9M
WACC	18.43%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	$72.7M
Current liabilities	$137.8M
Current ratio	0.53
Net working capital	$-85M
Quick ratio	0.46
Working capital	$-65.1M
Working capital turnover	0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.86%
Dividend yield	0%
Shareholder yield	-11.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$16.79
1D price change	10.54%
1M price change	-3.34%
1M total return	-3.34%
1W price change	10.39%
1W total return	10.39%
1Y price change	-94.47%
1Y return CAGR	-94.48%
1Y total return	-94.47%
20-day SMA	$9.72
200-day SMA	$43.15
3M price change	-33.71%
3M total return	-33.71%
3Y price change	-73.02%
3Y return CAGR	-35.38%
3Y total return	-73.02%
50-day SMA	$11.34
50-day SMA vs 200-day SMA	50under200
52-week high	$309.60
52-week high date	2025-12-15
52-week low	$8.29
52-week low date	2026-10-20
5Y price change	-98.93%
5Y return CAGR	-59.64%
5Y total return	-98.93%
6M price change	-62.07%
6M total return	-62.07%
All-time high	$2,171.98
All-time high date	2019-12-12
All-time low	$8.29
All-time low date	2026-10-20
Average true range (ATR)	$0.96
Average volume	238.7K
Beta (1Y)	2.06
Beta (2Y)	1.54
Beta (5Y)	2.21
Change from 52-week high	-96.51%
Change from 52-week low	30.28%
Change from all-time high	-99.51%
Change from all-time low	27.56%
Change from open	12.27%
Day's gap	-1.54%
Dollar volume	$1.9M
High price	$10.80
Low price	$9.62
Monthly RSI	35.8
Open price	$9.62
Position in 52-week range	100%
Premarket change	0.82%
Premarket close	$9.77
Premarket price	$9.85
Previous close	$9.77
Price vs 150-day SMA	-37.03%
Price vs 20-day SMA	8.8%
Price vs 200-day SMA	-75.49%
Price vs 50-day SMA	-6.75%
Relative volume	0.73
Return from IPO open	-99.33%
Return from IPO price	-36.25%
RSI	53.3
Sharpe ratio	-1.04
Sharpe ratio (3Y)	0.25
Sharpe ratio (5Y)	-0.19
Sortino ratio	-1.24
Sortino ratio (3Y)	0.4
Sortino ratio (5Y)	-0.21
Volume	173.6K
Weekly RSI	29.52
YTD price change	-95.74%
YTD total return	-95.74%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.8M
Float percentage	62.57%
Shares change (QoQ)	40.42%
Shares change (YoY)	11.86%
Shares held by insiders	1.54%
Shares held by institutions	59.91%
Shares outstanding	6.1M
Short % of float	32.34%
Short % of shares	20.24%
Short ratio	4.6 days

Deeper analysis on GOSS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GOSS report

Is a complete GOSS research report available?

No complete published report is available for Gossamer Bio, Inc. (GOSS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Gossamer Bio, Inc. (GOSS)

Price

Financial snapshot

Fair-value bridge

Latest news · GOSS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GOSS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GOSS

Frequently asked questions